Madrigal Pharmaceuticals, Inc. technical analysis
Technical analysis of Madrigal Pharmaceuticals, Inc. (stock) with the Montbon Method — Elliott Waves, moving averages and a 0–100 score.
What is Madrigal Pharmaceuticals, Inc.
Madrigal Pharmaceuticals, Inc. is a biopharmaceutical company that develops therapeutics for metabolic dysfunction-associated steatohepatitis (MASH). The company offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. Founded in 2016, Madrigal Pharmaceuticals is headquartered in West Conshohocken, Pennsylvania.
Description generated automatically from public sources; it may be inaccurate or out of date.
Madrigal Pharmaceuticals, Inc.: latest session data
Closing values for September 2, 2026, computed on the last 12 months of prices.
Moving averages
21 sessions
525.12 $
+4.15%
50 sessions
528.39 $
+3.51%
200 sessions
515.25 $
+6.15%
Session levels
s2
524.05
Support
s1
531.38
Support
pivot
539.99
Pivot
r1
547.32
Resistance
r2
555.93
Resistance
How to read it
In the September 2, 2026 session Madrigal Pharmaceuticals, Inc. closed higher at 546.93 $, +1.53% versus the previous session.
The price sits above every moving average observed: +4.15% against the 21-session average, +3.51% against the 50 and +6.15% against the 200.
The 14-period RSI reads 57.5, in neutral territory.
MACD stands at 4.880 against a signal line at 1.998: the histogram is positive (+2.882).
ADX reads 11.8, indicating weak directionality.
Levels computed on the latest session place supports at 531.38 and 524.05 $ and resistances at 547.32 and 555.93 $, around a pivot of 539.99.
The average daily range (ATR) is 20.331 $, or 3.72% of price.
Turnover was 202.8K shares, 79% of the 20-session average.
Over the last twelve months the price ranged between 427.76 and 572.20 $, and today stands −4.42% from the period high.
Measures computed on closing prices. They describe the past; they are not forecasts.
Score, Elliott Waves, moving averages and technical indicators — free, no card
If you're not registered we'll ask you to sign in (free), then open the MDGL analysis.
How Montbon’s technical analysis works
Montbon analyses markets with Elliott Waves, multi-timeframe moving averages and a 0–100 score summarising the technical setup. It is an informational screening tool.
Elliott Waves
Wave counting to frame the price structure.
MTF moving averages
Moving averages across timeframes to read the trend.
0–100 score
A technical summary of the setup, updated daily.
FAQ about Madrigal Pharmaceuticals, Inc.
How is Madrigal Pharmaceuticals, Inc. analysed technically?
Technical analysis of Madrigal Pharmaceuticals, Inc. is based on price charts and indicators such as moving averages, RSI and MACD, to observe trend, momentum and volatility across different time horizons.
Which timeframes are used for Madrigal Pharmaceuticals, Inc.?
The daily and weekly charts are typically used for medium-to-long-term trends, while intraday charts (for example 1-hour or 15-minute) are used for short-term movements.
What are Elliott Waves applied to Madrigal Pharmaceuticals, Inc.?
Elliott Wave theory describes price moves as sequences of impulsive and corrective waves; applied to Madrigal Pharmaceuticals, Inc. it helps frame the technical structure of the historical chart and is not a forecast.
Other tickers to analyse
Disclaimer. For informational purposes only; not financial advice or a recommendation. Montbon Analytics is not an authorised financial intermediary.
Are you an issuer and want a correction or removal? Write to info@montbon.com.